ADCT
Price
$2.23
Change
-$0.00 (-0.00%)
Updated
May 23, 01:45 PM (EDT)
Capitalization
221.17M
81 days until earnings call
CASI
Price
$1.89
Change
-$0.03 (-1.56%)
Updated
May 23, 04:51 PM (EDT)
Capitalization
29.28M
Interact to see
Advertisement

ADCT vs CASI

Header iconADCT vs CASI Comparison
Open Charts ADCT vs CASIBanner chart's image
ADC Therapeutics SA
Price$2.23
Change-$0.00 (-0.00%)
Volume$100
Capitalization221.17M
CASI Pharmaceuticals
Price$1.89
Change-$0.03 (-1.56%)
Volume$100
Capitalization29.28M
ADCT vs CASI Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. CASI commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and CASI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (ADCT: $2.23 vs. CASI: $1.92)
Brand notoriety: ADCT and CASI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 232% vs. CASI: 127%
Market capitalization -- ADCT: $221.17M vs. CASI: $29.28M
ADCT [@Biotechnology] is valued at $221.17M. CASI’s [@Biotechnology] market capitalization is $29.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileCASI’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • CASI’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than CASI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 6 TA indicator(s) are bullish while CASI’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 6 bullish, 4 bearish.
  • CASI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than CASI.

Price Growth

ADCT (@Biotechnology) experienced а +31.95% price change this week, while CASI (@Biotechnology) price change was +6.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.76%, and the average quarterly price growth was -2.87%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

CASI is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($221M) has a higher market cap than CASI($29.3M). ADCT YTD gains are higher at: 12.060 vs. CASI (-32.155). CASI has higher annual earnings (EBITDA): -31.62M vs. ADCT (-110.43M). ADCT has more cash in the bank: 274M vs. CASI (20.8M). CASI has less debt than ADCT: CASI (19.1M) vs ADCT (125M). ADCT has higher revenues than CASI: ADCT (70.7M) vs CASI (22.1M).
ADCTCASIADCT / CASI
Capitalization221M29.3M754%
EBITDA-110.43M-31.62M349%
Gain YTD12.060-32.155-38%
P/E RatioN/AN/A-
Revenue70.7M22.1M320%
Total Cash274M20.8M1,317%
Total Debt125M19.1M654%
FUNDAMENTALS RATINGS
CASI: Fundamental Ratings
CASI
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTCASI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.280.12
+10.34%
NOVONIX Limited
BIDU85.48N/A
N/A
Baidu
DEA21.03N/A
N/A
Easterly Government Properties
USEG1.25N/A
N/A
US Energy Corp
VMI312.62-0.89
-0.28%
Valmont Industries

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+13.20%
QTTB - ADCT
48%
Loosely correlated
N/A
CLRB - ADCT
44%
Loosely correlated
N/A
AURA - ADCT
42%
Loosely correlated
N/A
IMNM - ADCT
41%
Loosely correlated
+6.82%
RGNX - ADCT
40%
Loosely correlated
N/A
More